NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/05/2023
Voltar para busca
Dado oficial do USPTO
HCI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HCI
ST13
US500000097169341Classe
35, 36, 42, 44
Pedido
97169341
Registro
7040282
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
18
Atualização mais recente
02/05/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 42, 44
Data de depósito
13/12/2021
Data de registro
02/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/05/2023
Última transação
02/05/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
30/06/2017
Primeiro uso no comércio
30/06/2017
Código do desenho
4
Tipo de titular
16
Localização do titular
GRAND ISLAND, NY, US
Examinador
MCBRIDE, THEODORE
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
HYBRID CONCEPTS INTERNATIONAL, LLC
Representantes
JOHN P. MURTAUGH PEARNE & GORDON LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Assistanceadvisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesregulatory affairs including preclinicalclinical and commercial stagepharmaceutical preclinical and clinical researchdevelopmentchemistrymanufacturing and controlsquality assurance/quality control; Business consulting servicesproviding assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support servicesbusiness consulting to freelancersstart-upsexisting businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA productclinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigationresearch and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations
Classe 36
Financial consulting servicesadvising others regarding intellectual property investments; Investment consultation in the fields of producttechnicalregulatorypreclinicalclinicalcommercial diligence for innovative potential or investigational medical products
Classe 42
Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Medical and scientific research information in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesregulatory affairs including preclinicalclinical and commercial stagepharmaceutical preclinical and clinical researchdevelopmentmanufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological servicesscientific research in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesscientific research for preclinicalclinical and commercial stage pharmaceuticalspharmaceutical preclinical and clinical researchdevelopmentquality assurance/quality control; Scientific research consulting in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesscientific research for preclinicalclinical and commercial stage pharmaceuticalspharmaceutical preclinical and clinical researchdevelopmentquality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesscientific research for preclinicalclinical and commercial stage pharmaceuticalspharmaceutical preclinical and clinical researchdevelopmentquality assurance/quality control; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics
Classe 44
Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
18 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/02/2023
PUBO
PUBLISHED FOR OPPOSITION
14/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/12/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/11/2022
GNRT
NON-FINAL ACTION E-MAILED
17/11/2022
CNRT
NON-FINAL ACTION WRITTEN
17/11/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/11/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/09/2022
DOCK
ASSIGNED TO EXAMINER
19/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/12/2021
NWAP
NEW APPLICATION ENTERED
16/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HCI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.